You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

CLINICAL TRIALS PROFILE FOR RITANSERIN

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Ritanserin

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000187 ↗	Ritanserin in Treatment of Cocaine Dependence - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00000187 ↗	Ritanserin in Treatment of Cocaine Dependence - 1	Completed	University of Pennsylvania	Phase 2	The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
NCT00206765 ↗	Risperidone vs. Paroxetine for Panic Attacks	Terminated	Beth Israel Medical Center	Phase 2	We are comparing the efficacy of Risperidone versus Paroxetine in the treatment of panic symptoms. The study hypothesis is that Risperidone will be a superior medicine for treating panic.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Ritanserin

Condition Name

Chart
Table

Condition Name for
Intervention	Trials
Panic Disorder	2
Cocaine-Related Disorders	1
Major Depression With Panic Attacks	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for
Intervention	Trials
Depressive Disorder, Major	2
Panic Disorder	2
Depressive Disorder	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Ritanserin

Trials by Country

Map
Table

Trials by Country for
Location	Trials
United States	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for
Location	Trials
New York	2
Pennsylvania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Ritanserin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 2	2
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	2
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ritanserin

Sponsor Name

Chart
Table

Sponsor Name for
Sponsor	Trials
Beth Israel Medical Center	2
National Institute on Drug Abuse (NIDA)	1
University of Pennsylvania	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for
Sponsor	Trials
Other	3
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.